(Press-News.org) PHOENIX -- If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined.
In a study released online in April in the BMJ, a team of researchers from Mayo Clinic, and other collaborators, showed that for older patients, particularly individuals greater than 75 years of age, the risk of gastrointestinal (GI) bleeding is 3 to 5 times higher when taking newer anticoagulant medications dabigatran or rivaroxaban compared to when using warfarin.
One of the most common reasons people take anticoagulant medication - which lessens the blood's tendency to clot - is to reduce potential or severity of clotting complications in patients with atrial fibrillation or venous thromboembolism. People with atrial fibrillation and venous thromboembolism have a much higher risk of strokes, heart attacks and clots in the lungs and legs, which can result in disability or death.
Use of anticoagulants lessens the likelihood of stroke and other clotting complications, but brings a different set of risks, one of which is excessive bleeding due to reduced ability to form blood clots. Excessive GI bleeding in particular can itself be life threatening.
Warfarin has been in use since the 1950s, and is an effective anticoagulant. Because it is so powerful and long acting, users are required to have regular blood tests to monitor the effects.
The newer medications dabigatran and rivaroxaban are as effective as warfarin at preventing blood clots and reducing the risk of stroke and clotting complications, but do not require the regular monitoring. This convenience factor has resulted in an upswing in prescriptions for the newer medications as a replacement for warfarin.
However, convenience is not the only factor at play here, say the researchers.
"The new anticoagulants have really been popular with patients who have previously only had one choice of oral anticoagulant," says lead author Neena S. Abraham, M.D., "They greatly reduce the number of visits to the doctor for monitoring, and are much more convenient for patients. However, they may not be the right choice for everyone."
With so many treatment choices available, doctors and patients may have difficulty narrowing them down to 'the right choice.' This study helps pinpoint what appears to be a better choice for older individuals.
"In our study, by using the real-world, national data available from the Optum Labs Data Warehouse, we were able to determine that individuals over age 75 have a much higher risk of GI bleeds than younger patients, if using dabigatran or rivaroxaban instead of warfarin," says Dr. Abraham. "Our findings definitely point toward important age-related risk that merit consideration when doctors are making treatment recommendations. "
"We also saw that for patients under age 65, the newer agents appear to carry less risk of GI bleeds. At 65 this changes, and risk begins to increase until it exceeds the GI bleeding risk with warfarin at age 76 and older."
This a unique study, looking at adults of all ages who received anticoagulants, say the researchers, and thus has allowed a better understanding of the way these new drugs work for a broader group of people.
INFORMATION:
It is one of many projects ongoing in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery that seeks to improve the way patients experience health care.
The study's co-authors include: Sonal Singh, M.B.B.S., and G. Caleb Alexander, M.D., of Johns Hopkins; Herbert Heien, Lindsey Haas and Nilay Shah, Ph.D., of Mayo Clinic and Optum Labs, and William Crown, Ph.D., of Optum Labs.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic and http://newsnetwork.mayoclinic.org/.
MEDIA CONTACT: Jim McVeigh, Mayo Clinic Public Affairs, 480-301-4222, Email: mcveigh.jim@mayo.edu
At a traditional stone-laying ceremony outside La Serena, Chile on April 14th, construction officially began of the Large Synoptic Survey Telescope (LSST). This ambitious international astrophysics project is slated to start scanning the heavens in 2022. When it does, LSST should open up the "dark universe" of dark matter and dark energy--the unseen substance and force, respectively, composing 95 percent of the universe's mass and energy--as never before.
On April 2, 2015, the Director of LSST, Steven Kahn, along with astrophysicist Sarah Bridle and theoretical physicist ...
The study, published May 29 in the open access Nature Publishing Group journal Scientific Reports, reveals a direct link between the main culprit of Alzheimer's disease and memory loss.
Alzheimer's disease is characterized by the formation of amyloid plaques in the brain tissue. These amyloid plaques are made up of an insoluble protein, 'Amyloid-beta' (Abeta), which forms small structures called 'oligomers' that are important in the disease progression.
Although these proteins are known to be involved in Alzheimer's, little is understood about how they lead to memory ...
Stanford University scientists have created a new carbon material that significantly boosts the performance of energy-storage technologies. Their results are featured on the cover of the journal ACS Central Science.
"We have developed a 'designer carbon' that is both versatile and controllable," said Zhenan Bao, the senior author of the study and a professor of chemical engineering at Stanford. "Our study shows that this material has exceptional energy-storage capacity, enabling unprecedented performance in lithium-sulfur batteries and supercapacitors."
According to ...
One of the main health targets proposed by the UN Sustainable Development Goals (SDG) is to reduce by one-third premature mortality from non-communicable diseases such as cancer, stroke and dementia. The goals for 2016-2030 define premature mortality as deaths occurring among people aged 69 years old or younger.
The proposed SDG target sends an unambiguous statement to UN member states that health provision for younger groups must be prioritised at the expense of people aged 70 or more, according to the international group of signatories of the letter published in The ...
May 29, 2015 - Researchers are exploring new approaches to designing prosthetic hands capable of providing "sensory feedback." Advances toward developing prostheses with a sense of touch are presented in a special topic article in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Emerging sensory feedback techniques will provide some sensation and enable more natural, intuitive use of hand prostheses, according to the review by ASPS Member Surgeon Paul S. Cederna, MD, of University ...
May 29, 2015 - As in adults, migraine surgery is effective for selected adolescent patients with severe migraine headaches that don't respond to standard treatments, reports a study in the June issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
ASPS Member Surgeon Bahman Guyuron, MD, Emeritus professor of plastic surgery at Case School of Medicine, Cleveland, and colleagues report good outcomes in an initial experience with migraine surgery in younger patients. They write, "Our data demonstrate ...
May 29, 2015 - People with dementia and other forms of cognitive impairment (CI) have altered responses to pain, with many conditions associated with increased pain sensitivity, concludes a research review in PAIN®, the official publication of the International Association for the Study of Pain. The journal is published by Wolters Kluwer.
The available evidence questions the previous notion that people with CI have reduced pain sensitivity to pain. Rather, "It appears that those with widespread brain atrophy or neural degeneration...all show increased pain responses ...
The 54-question Trauma Symptoms Checklist for Children (TSCC) has been used for decades to test how trauma affects youth in hopes of developing the best treatment and support possible. But interpreting the results can be labor intensive and difficult because the work is done manually and involves a complex matrix from which to draw conclusions.
Now, a Case Western Reserve University social work research team, led by Fredrick Butcher, PhD, a research associate at the Semi J. and Ruth W. Begun Center for Violence Prevention Research and Education, has proposed and tested ...
(WASHINGTON, May 29, 2015) - A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology (ASH), proposes race-specific equations to help clinicians better calculate warfarin dosage.
Warfarin is the most widely used blood thinning medication, or anticoagulant, prescribed to prevent stroke and to treat blood clots. Determining the optimal warfarin dose to prevent clots while avoiding dangerous bleeding is difficult. To ensure ...
Cosmetics is an important industry worldwide and has attained high levels of sophistication. There are over 10,000 components that can be used to make cosmetics; so it is essential to monitor these components to guarantee consumer safety. Regulation 1223/2009 approved by the European Union in 2009 established a list of components that guarantee consumer safety as well as certain conditions for using these components, such as maximum concentration and what type of products they can be used in.
In his Ph.D. thesis, the researcher Josu López of the Department of Applied ...
